RLAY
- Relay Therapeutics, Inc.
()
Overview
Company Summary
Relay Therapeutics, Inc. is a biotechnology company that is focused on developing new medicines using a unique approach called dynamic protein motion. The company aims to address diseases that have been historically difficult to target with traditional drug discovery techniques.
Unlike traditional small molecule drugs, which primarily target static protein structures, Relay Therapeutics is interested in understanding how proteins move and change shape in order to design drugs that can modulate their function more effectively. By studying the dynamic nature of proteins, the company believes it can identify new therapeutic targets and discover innovative drug candidates.
Relay Therapeutics combines computational simulations and experimental techniques to analyze the movement of proteins and identify potential drug binding sites. This approach allows the company to create targeted therapies that can potentially address challenging diseases like cancer, genetic diseases, and immunological disorders.
The company's platform leverages technology such as molecular dynamics simulations and atomic resolution cryo-electron microscopy to gain insights into protein structures and dynamics. By mapping protein movements, Relay Therapeutics aims to discover and optimize small molecules that can interact with specific proteins to modulate their activity and potentially treat diseases.
Overall, Relay Therapeutics' mission is to harness the power of protein motion to develop groundbreaking therapies. By focusing on a novel approach to drug discovery, the company aims to make a significant impact on patient outcomes and bring innovative treatments to the market.